Harvey Knight

ekko is the mission-led fintech platform for banks and payments. From banking apps to checkout experiences, we make it easier for you to achieve your business objectives while meeting the growing consumer demand for purpose-driven services, empowering customers to take concrete climate action through every transaction. Founded by a team of experienced fintech and bank leaders, ekkos technology is partnered with brands around the world. Find out more about how to engage your customers whilst doing good at www.ekko.earth - Winner of SME of the Year at Sustainable Company Awards 2024 - Awarded Best New Digital Product of the Year at Global Retail Banking Innovation Awards 2024 - Winner of Best Achievement in Sustainability 2023 - Awarded Best Green Initiative in Payments 2022

PreCombTherapeutics AG is a privately held Swiss biotechcompany focused on in vitro cancer diagnostic to improve cancer management. It’s automated microtumor-based 3DTwin™ technology enables clinical institutions to integrate the technology on-site in the hospital. The test makes it possible to functionally evaluate multiple cancer drugs, drug combinations and drug concentrations directly on patient-derived micro-tumors to maximize treatment outcome.

The app for sustainable investments. Make an impact on climate change with your savings. Capital at risk.

Were the UKs highest rated recipe box that happens to be 100% plant-based. Forget about sloppy ready meals and ordering another takeaway. The joy and satisfaction of making food from scratch is where its at. But if you’ve spent decades using meat and dairy as core ingredients, you need a bit of culinary know-how to avoid munching on rabbit food. That’s where Grubby comes in… Were a proud certified B-Corp and our mission is to make plant-based cooking more accessible to the world by making it less faff and full of flavour. We started out delivering to office smart fridges in 2019. Then Covid hit and we had to apply the brakes. We were inspired to pivot to D2C after delivering over 1,000 free meals to the NHS during lockdown. Starting out on two bikes in North London armed with veg crates, we now deliver to thousands of plant curious Grubsters nationwide every week (many of which are still delivered by bike and the rest by carbon neutral couriers).

ALVÁTECH is an award winning sustainable Water & Climate Technology company. It’s disruptive technology enables - millions of growers and agri companies around the world battle climate change, save water and grow more crops. - insurance companies and banks reduce risk by providing crop protection - counties and states/countries increase irrigation water efficiency and protect water resources In a world facing severe climate changes and with the rising cost & scarcity of water and fertile soil ALVÁTECH is leading a sustainable, solar-powered, ecological water revolution. Join the water revolution for a better world. Help tackle climate change and provide food, nutrition and job security to farmers and communities around the world. W: www.alva-water.com LI: http://www.linkedin.com/company/alvatech-watertechnology E: info@alvatech.co.uk

Daphne Technology is dedicated to reducing methane emissions from gas-powered engines on land and at sea. Our innovative products reduce engine exhaust methane (aka ‘slip’) and provide real-time emissions data, enabling operators to meet stringent regulatory standards, enhance environmental responsibility, and improve operational efficiency. Backed by global industrial leaders, we are recognised for our contributions to a cleaner, more sustainable future.

Gravitricity develops long-life underground technologies that help solve the problem of intermittent renewable energy by storing excess energy during periods of low demand and releasing it back when required. Our innovative energy storage solutions include: fast-response, long-life gravity energy storage and flexible hydrogen storage which is designed to store large quantities of green hydrogen underground.

For people. For plants. For planet. We are a virtically integrated regenerative agriculture, biorefinery and biopolymer business built for a better future.

Discover, compare, and monitor EIS-relevant companies with structured data and market visibility — built for investors, advisers, and serious market participants.

ekko is the mission-led fintech platform for banks and payments. From banking apps to checkout experiences, we make it easier for you to achieve your business objectives while meeting the growing consumer demand for purpose-driven services, empowering customers to take concrete climate action through every transaction. Founded by a team of experienced fintech and bank leaders, ekkos technology is partnered with brands around the world. Find out more about how to engage your customers whilst doing good at www.ekko.earth - Winner of SME of the Year at Sustainable Company Awards 2024 - Awarded Best New Digital Product of the Year at Global Retail Banking Innovation Awards 2024 - Winner of Best Achievement in Sustainability 2023 - Awarded Best Green Initiative in Payments 2022

We connect the world’s leading institutional asset owners—those managing £25 billion+ in AUM—through peer-to-peer insight, debate and shared intelligence. Sustainable Investor is a global media and content platform dedicated to the people and policies shaping long-term capital. Our audience includes CIOs, sustainability leads, trustees and consultants focused on governance, private markets, transition finance and long-horizon risk. We navigate the pressures asset owners face every day: regulatory divergence, data saturation, transition credibility, and the challenge of delivering sustainable outcomes without compromising fiduciary discipline. We exist to help leaders cut through noise, learn from peers, and stay ahead of structural change.

PreCombTherapeutics AG is a privately held Swiss biotechcompany focused on in vitro cancer diagnostic to improve cancer management. It’s automated microtumor-based 3DTwin™ technology enables clinical institutions to integrate the technology on-site in the hospital. The test makes it possible to functionally evaluate multiple cancer drugs, drug combinations and drug concentrations directly on patient-derived micro-tumors to maximize treatment outcome.